After the introduction of fluorescent reporter genes, these modified viruses have a variety of applications in scientific research. With the approval of GSK and Pfizer's RSV vaccines in 2023, RSV vaccine and drug development research has become a hot topic, and genetically engineered viruses are an important research tool.